An experimental drug from Lilly has shown promise for weight loss, with some reports indicating it has hit its goal in a trial. The drug, which is also being studied for diabetes, has yielded significant weight loss in a study, although the stage of the trial is unclear, with some outlets describing it as mid-stage and others as late-stage. The drug's efficacy for both diabetes and weight management has been reported.